FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

39382911000001108: Bimatoprost 300micrograms/ml eye drops 0.4ml unit dose preservative free (Aspire Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Mar 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
608591000001112 Bimatoprost 300micrograms/ml eye drops 0.4ml unit dose preservative free (Aspire Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
608601000001115 Bimatoprost 300micrograms/ml eye drops 0.4ml unit dose preservative free (Aspire Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bimatoprost 300micrograms/ml eye drops 0.4ml unit dose preservative free (Aspire Pharma Ltd) Has unit of administration drop false Inferred relationship Existential restriction modifier
Bimatoprost 300micrograms/ml eye drops 0.4ml unit dose preservative free (Aspire Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Bimatoprost 300micrograms/ml eye drops 0.4ml unit dose preservative free (Aspire Pharma Ltd) Is a Bimatoprost 300micrograms/ml eye drops 0.4ml unit dose preservative free true Inferred relationship Existential restriction modifier
Bimatoprost 300micrograms/ml eye drops 0.4ml unit dose preservative free (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Bimatoprost 300micrograms/ml eye drops 0.4ml unit dose preservative free (Aspire Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Bimatoprost 300micrograms/ml eye drops 0.4ml unit dose preservative free (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Preservative free true Inferred relationship Existential restriction modifier
Bimatoprost 300micrograms/ml eye drops 0.4ml unit dose preservative free (Aspire Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Bimatoprost 300micrograms/ml eye drops 0.4ml unit dose preservative free (Aspire Pharma Ltd) Has specific active ingredient Bimatoprost true Inferred relationship Existential restriction modifier
Bimatoprost 300micrograms/ml eye drops 0.4ml unit dose preservative free (Aspire Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Bimatoprost 300micrograms/ml eye drops 0.4ml unit dose preservative free (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Bimatoprost 300micrograms/ml eye drops 0.4ml unit dose preservative free (Aspire Pharma Ltd) Has dispensed dose form Conventional release eye drops true Inferred relationship Existential restriction modifier
Bimatoprost 300micrograms/ml eye drops 0.4ml unit dose preservative free (Aspire Pharma Ltd) Has unit of administration drop false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Bimatoprost 300micrograms/ml eye drops 0.4ml unit dose preservative free (Aspire Pharma Ltd) 30 unit dose 6 x 5 unit doses Has AMP True Bimatoprost 300micrograms/ml eye drops 0.4ml unit dose preservative free (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start